Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Merck (MRK) : "I'm not a buyer of Merck, I prefer Eli Lilly (LLY) or Abbott Laboratories (ABT) ."

Phillips 66 (PSX) : "They are well run and can create real value there."

Five Below (FIVE) : "I've always believed in this one. They own this business."

Cintas (CTAS) : "This is one of my absolute favorites. They are terrific operators."

Cramer and the AAP team are pouncing on the recent weakness in Raytheon (RTN) . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

On Real Money, Cramer says the pajama traders had better get with the program. Get more of Cramer's insights with a free trial subscription to Real Money.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had a position in RTN,LLY, ABT.

More from Jim Cramer

Jim Cramer Gets Quizzed on Cannabis

Jim Cramer Gets Quizzed on Cannabis

Should Yahoo Finance Be Afraid of the Big, Bad Apple? Jim Cramer Says Yes

Should Yahoo Finance Be Afraid of the Big, Bad Apple? Jim Cramer Says Yes

Too Many Reasons to Sell: Cramer's 'Mad Money' Recap (Monday 10/22/18)

Too Many Reasons to Sell: Cramer's 'Mad Money' Recap (Monday 10/22/18)

Dropbox, Albermarle, Palo Alto Networks: 'Mad Money' Lightning Round

Dropbox, Albermarle, Palo Alto Networks: 'Mad Money' Lightning Round

Rewind: Jim Cramer's Reveals His Concern About Earnings Season

Rewind: Jim Cramer's Reveals His Concern About Earnings Season